SABRIL (FOR ORAL SOLUTION) Adverse Event: Cardiac arrest
SABRIL (FOR ORAL SOLUTION) Adverse Event: Cardiac arrest is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: SABRIL (FOR ORAL SOLUTION); Product category: Drug; Primary reaction: Cardiac arrest.
| Primary drug | SABRIL (FOR ORAL SOLUTION) |
|---|---|
| Product category | Drug |
| Primary reaction | Cardiac arrest |
| All reactions | Cardiac arrest; Arrhythmia; Acidosis; Respiratory distress; Status epilepticus |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Female |
| All drugs reported | SABRIL (FOR ORAL SOLUTION); ONFI; VIMPAT; DIAZEPAM |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10003853 |
$299/mo
Try FDATracker →